| |
|
|
ILSUNG PHARMACEUTICALS CO.,LTD. (003120) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
141,000 | 118,500 | 71,800 | 105,000 |
| Yearly Lowest Price |
77,700 | 43,950 | 54,100 | 60,500 |
| Common Shares O/S |
2,660,000 | 2,660,000 | 2,660,000 | 2,660,000 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
2,992 | 1,915 | 1,686 | 1,907 |
| Dividends (%) |
10.0 | 10.0 | 10.0 | - |
|
 |
(Company/Sector/Market) |
| |
2009.06 | 2010.06 |
| Beta |
0.59 / 0.54 / 1.00 | 0.52 / 0.55 / 1.00 |
| Volatility |
53.87 / 32.47 / 41.28 | 36.14 / 20.53 / 17.70 |
|
 |
(unit : Won) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Earnings Per Share |
6,700 | 14,046 | 4,215 | 4,350 |
| Sales Per Share |
29,841 | 32,837 | 37,422 | 25,480 |
| Book Value Per Share |
150,375 | 92,645 | 116,957 | 121,847 |
| Cash Flow Per Share |
1,579.05 | 6,798.51 | 662.46 | 8,020.28 |
|
 |
(Unit : Times) |
| Fiscal Year End |
07.12 | 08.12 | 09.12 | 10.09 |
| Price / Earnings (H/L) |
21.04/11.60 | 8.44/3.13 | 17.03/12.84 | 24.13/13.91 |
| Price / Sales (H/L) |
4.72/2.60 | 3.61/1.34 | 1.92/1.45 | 4.12/2.37 |
| Price / Book (H/L) |
0.94/0.52 | 1.28/0.47 | 0.61/0.46 | 0.86/0.50 |
| Price / Cash Flow (H/L) |
89.29 / 49.21 | 17.43 / 6.46 | 108.38 / 81.67 | 13.09 / 7.54 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
06.12 |
07.12 |
08.12 |
09.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
524 |
714 |
572 |
708 |
592 |
940 |
700 |
1,048 |
| NOPLAT |
151 |
54 |
145 |
60 |
121 |
70 |
91 |
143 |
| Return on Invested Capital |
28 |
7 |
25 |
8 |
20 |
7 |
13 |
13 |
| WACC |
5 |
6 |
6 |
6 |
6 |
6 |
5 |
6 |
| Economic Value Added |
121.0 |
8.6 |
110.0 |
10.9 |
81.6 |
5.3 |
51.9 |
75.1 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2007.12 | 2008.12 | 2009.12 | 2010.09 |
| Enterprise Value(EV) |
2,992.50 | 1,915.20 | 1,686.44 | 1,907.22 |
| EBITDA |
219.46 | 220.82 | 153.29 | 94.46 |
| EBITDA/Sales |
0.28 | 0.28 | 0.21 | 0.14 |
| EBITDA/Financial Exp. |
659.92 | 69.56 | 88.10 | 175.34 |
| EV/EBITDA |
13.64 | 8.67 | 11.00 | 20.19 |
|
|
|
|
